Cargando...
New perspectives for targeting RAF kinase in human cancer
The discovery that a subset of human tumours is dependent on mutationally deregulated BRAF kinase intensified the development of RAF inhibitors to be used as potential therapeutics. The US Food and Drug Administration (FDA)-approved second-generation RAF inhibitors vemurafenib and dabrafenib have el...
Guardado en:
| Publicado en: | Nat Rev Cancer |
|---|---|
| Autores principales: | , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
2017
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6000833/ https://ncbi.nlm.nih.gov/pubmed/28984291 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/nrc.2017.79 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|